ANI PR Wire
24 Nov 2022, 16:15 GMT+10
Mumbai (Maharashtra) [India], November 24 (ANI/NewsVoir): LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics testing company, announced it has launched its highly sensitive C-Reactive Protein (CRP) point of care antigen test across India.
The point of care CRP test can be used in multiple clinical settings to help reduce unnecessary antibiotic prescribing that leads to antimicrobial resistance. From a tiny sample of finger-prick blood, the CRP test gives results within four minutes on the portable LumiraDx platform which weighs just over a kilogram.
Today's announcement comes during World Antimicrobial Awareness Week (WAAW) which spotlights the increasing global burden of antimicrobial resistance.
With the new antibiotic pipeline almost dry, reducing antibiotic prescriptions, managing patient compliance to treatment, and reducing self-medication are vital to alleviate the global burden of drug-resistant pathogens.
Studies show that point of care CRP testing reduces antibiotic prescribing by 23-36% for respiratory tract infections (RTI)1, and 22 per cent for COPD2. Antimicrobial resistance (AMR) continues to be a high priority global issue 4,5 and there is a direct relationship between the prescribing of antimicrobials and the development of AMR. 6
CRP testing can effectively help to reduce unnecessary antibiotic prescribing in primary care.1
"India, one of the world's most populated nations has greatly been impacted by antimicrobial resistance. The availability of the LumiraDx CRP Point of Care Antigen Test can help to ensure that antibiotics are only given to patients who will benefit from them," said Yogesh Singh, LumiraDx General Manager, India.
"Global emergence of antimicrobial resistant pathogens presents an urgent need for practical and innovative solutions to control and prevent the use of antibiotics, especially where unnecessary prescriptions, self-medication and poor compliance persist," said Dr Nigel Lindner, Chief Innovation Officer, LumiraDx, "Ensuring doctors' access to crucial actionable CRP test results in care settings is a sustainable way to future proof our system against antibiotic resistance."
In India, CRP tests are available in ICUs, paediatric departments, EDs, GPs, OPDs, and other clinical care settings. The Government of India considers AMR a priority health issue and has undertaken a nationwide initiative by launching an AMR stewardship programme.
More information on LumiraDx is available at www.lumiradx.com.
1. Cooke J, Llor C, Hopstaken R, Dryden M, Butler C. Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI. BMJ Open Respir Res. 2020;7(1):e000624. doi:10.1136/bmjresp-2020-000624
2. Butler CC, Gillespie D, White P, et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med. 2019;381(2):111-120. doi:10.1056/NEJMoa1803185
3 . Neelam Taneja and Megha Sharma. Antimicrobial resistance in the environment: The Indian scenario. Indian J Med Res. 2019 Feb; 149(2): 119-128.
4. World Health Organisation (WHO). Global action plan on antimicrobial resistance, 2015.
5 O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: HM Government and Wellcome Trust, 2016.
6. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet
2005;365:579-87.
This story has been provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)
Get a daily dose of Herald Globe news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Herald Globe.
More InformationWASHINGTON, D.C.: President Donald Trump will meet Israeli Prime Minister Benjamin Netanyahu at the White House on Monday. President...
GENEVA, Switzerland: A new United Nations report alleges that dozens of global corporations are profiting from and helping sustain...
LONDON, UK - Lawmakers in the United Kingdom have voted overwhelmingly to proscribe the direct-action group Palestine Action as a terrorist...
DHARAMSHALA, India: The Dalai Lama is set to address a significant three-day conference of Buddhist leaders this week, coinciding with...
WASHINGTON, D.C.: In a significant ruling last week, the U.S. Supreme Court upheld a Texas law requiring age verification for users...
ISTANBUL/PARIS/BRUSSELS: As searing temperatures blanket much of Europe, wildfires are erupting and evacuation orders are being issued...
ABU DHABI, 3rd July, 2025 (WAM) -- The Department of Culture and Tourism - Abu Dhabi (DCT Abu Dhabi) and the National Basketball Association...
New Delhi [India], July 3 (ANI): The social media accounts of several Pakistani actors and cricketers remain blocked after it was reported...
Jaipur (Rajasthan) [India], July 2 (ANI): The much-anticipated LEGEN-Z T10 League will be played from August 7 to August 13 at the...
New Delhi [India], July 2 (ANI): The Board of Control for Cricket in India (BCCI) Ombudsman Justice (Retd) Arun Mishra has directed...
Mumbai (Maharashtra) [India], July 2 (ANI): Actor-comedian Kapil Sharma is back with another episode of 'The Great Indian Kapil Show,'...
Birmingham [UK], July 2 (ANI): Former head coach and cricketer Ravi Shastri didn't mince his words while expressing his discontent...